HEDIMED was featured in the European Commission’s Horizon Research & Innovation Magazine. Read the article “The hunt for clues to immune-system disorders” on how HEDIMED is taking approaches to understanding a growing group of illnesses in a bid for more effective treatments.
A celebration of science and the years of collaboration The HEDIMED Consortium gathered for its final meeting in Siena from April 8th to 11th, bringing together leading minds in exposome research for a vibrant and inspiring event. Hosted in the stunning historical Rettorato building, the meeting was a true celebration of science, collaboration, and shared…
From November 26th to 28th, the EHEN (European Human Exposome Network) final meeting took place in Brussels, bringing together researchers, stakeholders, and policymakers to discuss the network’s achievements and future directions. The event was divided into two-day scientific meeting followed by a one day stakeholder event, each packed with inspiring presentations and lively discussions. Two…
We hope you had a relaxing Christmas break – we are now ready to get back to business and start new activities in the project! Towards the end of last year, HEDIMED admin team was busy with submitting the project’s first periodic report, describing the progress carried out during the first 18 months of the…
11th of February 2020 The nine projects of the European Human Exposome Network had a common launching event on February 10th in Brussels. The event took place in the European Commission, Charlemagne building, Room Alcide De Gasperi. It was a one-day fruitful event with keynote speeches by exposome experts, Christopher Wild (Emeritus Director, International Agency…
A quick throwback into EASD2024, held in Madrid in 9th-13th September: This year, EASD brought together a large and engaged audience of more than 12,000 people, with particular interest in Type 1 Diabetes. The event, designed to bridge the gap between scientific discoveries and public health, featured key presentations and discussions about the disease. HEDIMED…
After a busy first half of the year, we want to wrap up some past events and highlight the upcoming ones. Our science has taken big steps and we are glad to announce that some practical steps, such as samples transfers to different laboratories are in active phase, meaning lab analyses are also ongoing and…